If necessary, a vaccine against the emerging omicron variant can be developed “very quickly”. This was stated by Professor Andrew Pollard, the British scientist who led the research behind the coronavirus vaccine developed by AstraZeneca. “It is extremely unlikely that, as we saw last year (with the Delta variant, ed), there will be a restart of a pandemic in a vaccinated population,” the director of the Oxford Vaccine Group told BBC radio. that existing vaccines are expected to work against the new strain, but for confirmation it will be necessary to wait for further studies in the coming weeks. examined very quickly, “he added.